6569
醫揚
+1.30 (+1.45%)91.207成交張數19.13本益比2.26股價淨值比3.34%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入20251,313年增 +5.8%
毛利率202533.0%最新一期
營業利益率20254.0%最新一期
每股盈餘20252.88年增 -38.6%
| 會計項目 | 走勢 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | – | +9.9% | +4.1% | -9.1% | -10.8% | +33.2% | -6.7% | -16.9% | +5.8% | |
| 營業成本合計 | – | +11.5% | -2.1% | -6.1% | -5.1% | +34.6% | -17.0% | -16.2% | +12.0% | |
| 營業毛利（毛損） | – | +6.8% | +16.8% | -14.5% | -21.6% | +29.9% | +17.8% | -18.0% | -4.9% | |
| 營業毛利（毛損）淨額 | – | +6.8% | +16.8% | -14.5% | -21.6% | +29.9% | +17.8% | -18.0% | -4.9% | |
| 推銷費用 | – | +1.9% | +1.7% | +3.1% | -13.7% | +16.2% | +11.9% | -5.7% | +9.6% | |
| 管理費用 | – | +14.0% | +10.8% | +2.4% | -1.4% | +14.5% | -2.4% | -1.6% | +9.6% | |
| 研究發展費用 | – | -3.8% | +4.3% | -0.5% | +15.6% | +9.2% | -8.4% | +49.1% | -4.9% | |
| 預期信用減損損失（利益） | – | – | – | -77.7% | -64.7% | -249.6% | – | – | -211.1% | |
| 營業費用合計 | – | +3.0% | +8.2% | -0.9% | -4.7% | +13.0% | +3.4% | +8.7% | +3.9% | |
| 營業利益（損失） | – | +13.3% | +30.3% | -32.1% | -53.6% | +95.1% | +50.0% | -59.3% | -41.1% | |
| 利息收入 | – | – | – | – | -79.4% | +616.1% | +204.3% | +146.6% | -67.3% | |
| 其他收入 | – | +339.3% | -79.2% | +93.3% | +51.4% | +77.9% | -52.9% | -1.3% | +45.1% | |
| 其他利益及損失淨額 | – | – | +37.9% | -106.2% | – | +218.3% | +23.0% | +186.7% | -140.4% | |
| 財務成本淨額 | – | +217.2% | +522.2% | -62.3% | +453.2% | +35.1% | +3.6% | +18.3% | +7.3% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | – | – | +79.1% | +48.0% | +25.4% | -0.1% | +6.7% | +2.1% | |
| 營業外收入及支出合計 | – | – | +15.2% | -21.3% | +56.4% | +47.3% | -10.1% | +35.5% | -40.8% | |
| 稅前淨利（淨損） | – | +59.3% | +27.2% | -30.1% | -30.8% | +72.7% | +26.0% | -32.3% | -40.9% | |
| 所得稅費用（利益）合計 | – | +34.4% | +48.9% | -30.7% | -63.9% | +185.9% | +28.1% | -47.3% | -61.2% | |
| 繼續營業單位本期淨利（淨損） | – | +65.1% | +23.1% | -30.0% | -23.3% | +60.6% | +25.6% | -29.4% | -38.0% | |
| 本期淨利（淨損） | – | +65.1% | +23.1% | -30.0% | -23.3% | +60.6% | +25.6% | -29.4% | -38.0% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | – | – | – | – | – | – | +861.2% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目 | – | – | – | -207.1% | – | – | -65.5% | -112.7% | – | |
| 不重分類至損益之項目： | – | – | – | – | – | – | -124.4% | – | +732.7% | |
| 國外營運機構財務報表換算之兌換差額 | – | – | -227.7% | – | – | – | -96.3% | – | -106.2% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | – | – | – | -80.5% | +769.0% | -62.3% | |
| 與可能重分類之項目相關之所得稅 | – | – | -292.7% | – | – | – | -96.3% | – | -106.2% | |
| 後續可能重分類至損益之項目： | – | – | – | – | – | – | -95.3% | – | -99.6% | |
| 其他綜合損益（淨額） | – | – | – | – | – | – | -106.8% | – | +169.4% | |
| 本期綜合損益總額 | – | +47.2% | +37.7% | -29.2% | -24.1% | +80.2% | +16.0% | -25.2% | -27.2% | |
| 母公司業主（淨利∕損） | – | +68.2% | +22.8% | -30.2% | -23.7% | +59.1% | +25.8% | -29.1% | -38.0% | |
| 非控制權益（淨利∕損） | – | – | – | – | – | – | -152.6% | – | – | |
| 母公司業主（綜合損益） | – | +50.3% | +37.1% | -29.4% | -24.5% | +78.5% | +16.1% | -24.9% | -27.3% | |
| 非控制權益（綜合損益） | – | – | – | – | – | – | -152.6% | – | – | |
| 基本每股盈餘 | – | +68.2% | +11.7% | -44.2% | -30.5% | +47.9% | +22.6% | -38.7% | -38.6% | |
| 繼續營業單位淨利（淨損） | – | +67.8% | +11.8% | -44.2% | -30.5% | +47.6% | +22.4% | -38.7% | -38.3% | |
| 稀釋每股盈餘 | – | +67.8% | +11.8% | -44.2% | -30.5% | +47.6% | +22.4% | -38.7% | -38.3% |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。